HLA-B27 Allele Detection by PCR at Chughtai Lab

HLA-B27 Allele Detection by PCR at Chughtai Lab

The Human Leukocyte Antigen B27 (HLA-B27) is a specific class I surface glycoprotein encoded by the B locus in the major histocompatibility complex (MHC) on chromosome 6. The HLA-B27 Allele Detection by PCR at Chughtai Lab is a highly specialized molecular diagnostic test designed to identify the presence of this specific genetic marker in a patient’s genomic DNA. Unlike traditional serological methods or flow cytometry, which can sometimes yield ambiguous results due to cross-reactivity with other HLA alleles (such as HLA-B7), Polymerase Chain Reaction (PCR) technology offers unparalleled sensitivity and specificity. By directly amplifying the target DNA sequence of the HLA-B27 gene, PCR ensures an extremely accurate qualitative determination of the allele’s presence or absence.

The clinical importance of the HLA-B27 allele lies in its exceptionally strong association with a group of chronic inflammatory joint diseases known collectively as seronegative spondyloarthropathies. The most prominent among these is ankylosing spondylitis, a debilitating inflammatory arthritis primarily affecting the spine and sacroiliac joints. Additionally, HLA-B27 is closely linked to reactive arthritis (formerly known as Reiter’s syndrome), psoriatic arthritis, enteropathic arthritis (associated with inflammatory bowel disease), and acute anterior uveitis (inflammation of the middle layer of the eye). While the presence of the HLA-B27 allele does not act as a standalone diagnosis for any of these conditions—as many healthy individuals carry the gene without ever developing symptoms—it serves as a critical diagnostic tool. When combined with clinical symptoms, physical examinations, and imaging modalities like digital X-rays or MRI, the detection of HLA-B27 significantly elevates the diagnostic certainty, allowing rheumatologists and physicians to formulate targeted, early-intervention treatment plans that can prevent irreversible joint damage and improve the patient’s long-term quality of life.

Clinical Procedure: What to Expect

Patient Preparation

Preparing for the HLA-B27 Allele Detection by PCR at Chughtai Lab is straightforward, as it is a non-invasive molecular blood test. Patients should observe the following guidelines to ensure a smooth sample collection process:

• No Fasting Required: Unlike metabolic or lipid panels, you do not need to fast before this test. You may eat and drink normally prior to your appointment.
• Medication Disclosure: Inform the healthcare staff and your referring physician about all medications, immunosuppressants, or biological therapies you are currently taking. Generally, these do not interfere with genomic DNA PCR testing, but maintaining an accurate clinical record is vital.
• Hydration: Drink plenty of water before the procedure. Being well-hydrated makes your veins more accessible, facilitating an easier and faster venipuncture process.
• Prior Blood Transfusions: If you have received a blood transfusion within the last few weeks, inform the laboratory staff. Recent transfusions can occasionally introduce donor DNA, which may affect the accuracy of molecular genetic testing.

During the Procedure

The sample collection process is conducted under strict aseptic conditions by experienced phlebotomists at Chughtai Lab. Here is what you can expect during the procedure:

• Patient Identification and Verification: The phlebotomist will first verify your identity using your prescription and national identity details to ensure absolute accuracy in labeling and tracking.
• Positioning: You will be asked to sit comfortably in a specialized phlebotomy chair. You should extend your arm, resting it on the armrest.
• Vein Selection: The phlebotomist will apply a sterile tourniquet around your upper arm to make the veins in your antecubital fossa (inner elbow) more prominent. They will palpate the area to select the most suitable vein, typically the median cubital vein.
• Sanitization: The selected site will be thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) to eliminate surface bacteria and prevent contamination.
• Venipuncture: A sterile, single-use needle attached to an EDTA (purple-top) vacuum tube will be gently inserted into the vein. You may feel a brief, minor pinch or prick as the needle enters.
• Sample Collection: The required volume of whole blood (typically 3 to 5 mL) will be drawn into the EDTA tube. The EDTA anticoagulant is crucial as it preserves the integrity of the white blood cells, from which genomic DNA will be extracted.
• Needle Removal and Hemostasis: Once the sample is collected, the tourniquet is released, the needle is gently withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to stop any bleeding. A small adhesive bandage will then be applied.
• Duration and Safety: The entire blood collection process takes less than five minutes. All materials used are strictly sterile and disposable, completely eliminating any risk of cross-infection.

When is an HLA-B27 Allele Detection by PCR Performed?

Suspected Ankylosing Spondylitis

Ankylosing spondylitis (AS) is a chronic, progressive inflammatory arthritis that primarily targets the sacroiliac joints and the axial skeleton. Physicians frequently order the HLA-B27 PCR test when a patient—particularly a young adult under the age of 45—presents with chronic lower back pain that has been persistent for more than three months. This inflammatory back pain is characteristically worse in the morning or after periods of inactivity, improves significantly with physical exercise, and is often accompanied by severe morning stiffness. Because early-stage AS may not show visible structural changes on conventional pelvic X-rays, detecting the HLA-B27 allele provides vital genetic evidence that supports a diagnosis of early axial spondyloarthritis, enabling timely therapeutic intervention.

Evaluation of Reactive Arthritis

Reactive arthritis is an autoimmune condition that develops in response to an infection originating in another part of the body, most commonly the gastrointestinal tract (caused by bacteria like Salmonella, Shigella, or Campylobacter) or the genitourinary tract (often due to Chlamydia trachomatis). The classic clinical presentation includes a triad of symptoms: urethritis, conjunctivitis, and asymmetric inflammatory arthritis, historically referred to as Reiter’s syndrome. Since a large percentage of patients who develop severe, chronic, or recurrent reactive arthritis are HLA-B27 positive, clinicians utilize this PCR test to assess the genetic predisposition, predict the likelihood of disease chronicity, and differentiate it from other acute arthropathies.

Investigation of Recurrent Anterior Uveitis

Anterior uveitis, or iridocyclitis, is the inflammation of the iris and the surrounding ciliary body in the eye. Patients typically present with sudden onset of eye pain, redness, photophobia (sensitivity to light), and blurred vision. While uveitis can occur secondary to localized ocular issues, recurrent or alternating bilateral episodes are highly correlated with systemic autoimmune conditions. Approximately 50% of patients presenting with acute anterior uveitis carry the HLA-B27 allele. Ophthalmologists and rheumatologists routinely request this molecular test to determine if the ocular inflammation is linked to an underlying systemic spondyloarthropathy, which requires systemic immunomodulatory treatment rather than localized ophthalmic therapy alone.

Diagnosis of Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis (JIA) encompasses several subtypes of chronic childhood arthritis. The HLA-B27 PCR test is particularly valuable when evaluating children who present with enthesitis-related arthritis (ERA). This subtype is characterized by joint inflammation combined with enthesitis—inflammation at the sites where tendons or ligaments attach to bone, such as the Achilles tendon insertion. Identifying the HLA-B27 allele in pediatric patients presenting with lower limb asymmetric arthritis or enthesitis helps pediatric rheumatologists classify the disease accurately, assess the risk of axial skeleton involvement as the child grows, and tailor aggressive management strategies to prevent long-term joint deformities.

Differentiating Inflammatory from Mechanical Back Pain

Lower back pain is one of the most common clinical complaints worldwide, with the vast majority of cases stemming from mechanical causes such as muscle strains, lumbar disc herniation, or degenerative disc disease. Distinguishing mechanical back pain from systemic inflammatory back pain is a major diagnostic challenge. While mechanical pain worsens with physical activity and improves with rest, inflammatory back pain behaves in the exact opposite manner. Clinicians order the HLA-B27 Allele Detection by PCR to help resolve this diagnostic dilemma. A positive result, in conjunction with elevated inflammatory markers like C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR), strongly points toward an inflammatory, autoimmune etiology rather than a mechanical musculoskeletal issue.

What Does an HLA-B27 Allele Detection by PCR Detect?

The HLA-B27 Allele Detection by PCR at Chughtai Lab is designed to evaluate, identify, and analyze several molecular and clinical parameters, including:

• The presence of the specific HLA-B27 genomic DNA sequence in the patient’s blood sample.
• The absence of the HLA-B27 allele, helping rule out this specific genetic predisposition.
• The extraction and purification of high-quality genomic DNA from peripheral blood leukocytes.
• The amplification of the target HLA-B27 gene region using sequence-specific primers.
• The validation of the PCR reaction using an internal control gene (such as beta-globin) to prevent false-negative results.
• The exclusion of PCR inhibitors that could interfere with DNA polymerase activity.
• A genetic risk factor associated with the development of Ankylosing Spondylitis.
• A genetic predisposition linked to the onset of Reactive Arthritis (Reiter’s Syndrome).
• An underlying genetic association in patients presenting with acute, recurrent anterior uveitis.
• The genetic basis for enthesitis-related arthritis in pediatric and juvenile populations.
• Supportive molecular evidence for the classification of seronegative spondyloarthropathies.
• A prognostic marker indicating a higher likelihood of severe, progressive, or erosive joint involvement.
• An aid in the differential diagnosis of seronegative rheumatoid-like arthritis from classic Rheumatoid Arthritis (RA).
• A genetic marker associated with psoriatic spondylitis and enteropathic arthropathies.
• The presence of genetic susceptibility in family members of patients diagnosed with HLA-B27-associated diseases.
• The molecular confirmation of clinical findings in patients with atypical or extra-articular manifestations.
• The genetic basis for chronic inflammatory back pain starting before the age of 45.
• The presence of HLA-B27 in patients presenting with isolated, unexplained heel pain (Achilles enthesitis).
• The molecular exclusion of HLA-B27 cross-reactive alleles that often cause false positives in serological assays.
• A critical diagnostic component within established international rheumatology classification criteria (such as the ASAS criteria).

Turnaround Time and Report Access at Chughtai Lab

At Chughtai Lab, molecular diagnostic procedures are performed under the highest quality controls using advanced Real-Time PCR platforms. The turnaround time for the HLA-B27 Allele Detection by PCR is typically within 24 to 48 hours from the time of sample collection. This rapid processing ensures that clinicians can quickly integrate the genetic data into their diagnostic workup. Once the analysis is finalized and verified by a Consultant Pathologist, patients receive an automated SMS notification. Reports can be accessed instantly online via the official Chughtai Lab website by entering the patient ID and lab number. Additionally, patients can download their reports through the user-friendly Chughtai Active mobile application or receive them directly on their registered WhatsApp number, ensuring maximum convenience and seamless digital access.

HLA-B27 Allele Detection Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
HLA-B27 Allele Presence	Negative (Not Detected)	Positive (Detected)
Internal Control Gene Amplification	Successfully Amplified (Valid Test)	Failed Amplification (Invalid Test / Re-run Required)
Genomic DNA Integrity	High-quality, intact genomic DNA extracted	Degraded DNA or low concentration (Inadequate sample)
PCR Amplification Curve	Flat baseline (No fluorescence signal detected)	Sigmoidal amplification curve exceeding threshold
Sample Quality / Hemolysis	No significant hemolysis or clotting	Severe hemolysis or micro-clots (May require redraw)
PCR Inhibitors	Absent (Unimpeded enzymatic reaction)	Present (Enzymatic reaction blocked, invalid result)
Clinical Correlation	No genetic association with HLA-B27 spondyloarthropathies	Strong genetic predisposition to Ankylosing Spondylitis, Uveitis, or Reactive Arthritis

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for HLA-B27 Allele Detection?

• Experienced Healthcare Professionals: Our molecular biology department is staffed by highly trained scientists and led by experienced Consultant Pathologists who oversee all testing protocols.
• Patient-Focused Care: We prioritize patient comfort, safety, and clarity throughout the testing process, from sample collection to final reporting.
• Quality Diagnostic Services: Chughtai Lab adheres to strict international quality standards, participating in regular external quality assurance programs to ensure absolute accuracy.
• Professional Reporting: Our reports are designed to be clear, comprehensive, and highly structured, providing clinicians with the precise data they need for diagnosis.
• Modern Diagnostic Approach: We utilize state-of-the-art Real-Time PCR technology, which minimizes human error and eliminates the cross-reactivity issues common in older testing methods.
• Comfortable Environment: All of our nationwide collection centers are designed to offer a clean, hygienic, and welcoming environment for patients of all ages.
• Convenient Location: With an extensive network of over 300 collection centers across Lahore and throughout Pakistan, finding a Chughtai Lab near you is effortless.
• Commitment to Accurate Diagnosis: We understand the life-changing impact of chronic autoimmune diseases, and we are dedicated to delivering reliable genetic insights that pave the way for effective treatment.